Segmental Outgrowth-lipomatosis-arteriovenous Malformation-epidermal Nevus Syndrome
Description
Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome is a rare, genetic, polymalformative syndrome characterized by progressive, proportionate, asymmetric segmental overgrowth (with soft tissue hypertrophy and ballooning effect) that develops and progresses rapidly in early childhood, arteriovenous and lymphatic vascular malformations, lipomatosis and linear epidermal nevus (arranged in whorls along the lines of Blaschko). Clinical symptoms of Cowden syndrome, such as macrocephaly and progressive development of numerous hypertrophic hamartomatous and neoplastic lesions involving multiple organs and systems, are also associated. Patients present an increased risk of developing cancer.
Genes related to Segmental Outgrowth-lipomatosis-arteriovenous Malformation-epidermal Nevus Syndrome
- PTEN
Clinical Features
Top most frequent phenotypes and symptoms related to Segmental Outgrowth-lipomatosis-arteriovenous Malformation-epidermal Nevus Syndrome
- Macrocephaly
- Congestive heart failure
- Papule
- Talipes
- Recurrent fractures
- Subcutaneous nodule
- Reduced bone mineral density
- Hemiplegia/hemiparesis
- Hamartoma
- Ovarian neoplasm
And another 9 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Segmental Outgrowth-lipomatosis-arteriovenous Malformation-epidermal Nevus Syndrome Is also known as solamen syndrome.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Segmental Outgrowth-lipomatosis-arteriovenous Malformation-epidermal Nevus Syndrome Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
PTEN Comprehensive - Sequence & Deletion/Duplication Analysis.
By Baylor Miraca Genetics Laboratories (United States).
PTEN
Specificity
100 %
Genes
100 % |
PTEN Deletion/Duplication Analysis.
By Baylor Miraca Genetics Laboratories (United States).
PTEN
Specificity
100 %
Genes
100 % |
PTEN Deletion/Duplication Analysis (Prenatal Diagnosis).
By Baylor Miraca Genetics Laboratories (United States).
PTEN
Specificity
100 %
Genes
100 % |
PTEN Sequence Analysis.
By Baylor Miraca Genetics Laboratories (United States).
PTEN
Specificity
100 %
Genes
100 % |
PTEN Sequence Analysis (Familial Mutation/Variant Analysis).
By Baylor Miraca Genetics Laboratories (United States).
PTEN
Specificity
100 %
Genes
100 % |
PTEN Sequence Analysis (Prenatal Diagnosis).
By Baylor Miraca Genetics Laboratories (United States).
PTEN
Specificity
100 %
Genes
100 % |
Hereditary High Risk Breast Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
BRCA1, BRCA2, STK11, TP53, CDH1, PALB2, PTEN
Specificity
15 %
Genes
100 % |
Hereditary High Risk Breast Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
BRCA1, BRCA2, STK11, TP53, CDH1, PALB2, PTEN
Specificity
15 %
Genes
100 % |
You can get up to 416 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like TREMOR, HEREDITARY ESSENTIAL, 5; ETM5